Početna › Rak vrata maternice › Oklahoma
Kliničke studije za Rak vrata maternice u državi Oklahoma
11 studija za Rak vrata maternice traži sudionike na lokacijama u državi Oklahoma.
Gradovi u državi Oklahoma
Službeni tekst studije (engleski)
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
U tijeku regrutacijaFaza 4
Od 18 godina i više · Žene · Ažurirano 25. ruj 2026. · NCT06952660A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Oklahoma Cancer Specialists and Research Institute, LLC ( Site 6001), Tulsa
U tijeku regrutacijaFaza 3
Od 18 godina i više · Žene · Ažurirano 25. ruj 2026. · NCT07216703A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Oklahoma City
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT07182149Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
- University of Oklahoma Health Sciences Center, Oklahoma City
- University of Oklahoma, Oklahoma City
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 25 godina i više · Žene · Ažurirano 31. srp 2026. · NCT07281430A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- Stephenson Cancer Center, Oklahoma City
U tijeku regrutacija
Od 18 godina i više · Žene · Ažurirano 30. srp 2026. · NCT04831580A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- OU Health University of Oklahoma Medical Center, Oklahoma City
- Stephenson Cancer Center (chemo location), Oklahoma City
- University of Oklahoma Health Science Center, Oklahoma City
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 6. srp 2026. · NCT04389632A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
- Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 2. velj 2026. · NCT06319963A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Dren Investigational Site, Oklahoma City
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 7. sij 2026. · NCT06999187SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Tulsa
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
- Stephenson Cancer Center, Oklahoma City
U tijeku regrutacijaFaza 2
Od 18 do 99 godina · Žene · Ažurirano 22. lis 2025. · NCT05512208A Study of NX-1607 in Adults With Advanced Malignancies
- University of Oklahoma, Oklahoma City
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2025. · NCT05107674Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.